Search

Author/Creator Cohan, Stanley

1. The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide. Issue 4 (October 2021)

Authors:
Cohan, Stanley; Gervasi-Follmar, Tiffany; Kamath, Aneesh; Kamath, Vineetha; Chen, Chiayi; Smoot, Kyle; Baraban, Elizabeth; Edwards, Keith
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 7:Issue 4(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

Authors:
Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu...
Journal:
Lancet neurology
Issue:
Volume 21:Issue 7(2022)
Page Start:
608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study. (13th February 2019)

Authors:
Zivadinov, Robert; Kresa-Reahl, Kiren; Weinstock-Guttman, Bianca; Edwards, Keith; Burudpakdee, Chakkarin; Bergsland, Niels; Dwyer, Michael G; Khatri, Bhupendra; Thangavelu, Karthinathan; Chavin, Jeffrey; Mandel, Matt; Cohan, Stanley
Journal:
Journal of comparative effectiveness research
Issue:
Volume 8:Number 5(2019)
Page Start:
305
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study. Issue 1 (December 2016)

Authors:
Gold, Ralf; Radue, Ernst-Wilhelm; Giovannoni, Gavin; Selmaj, Krzysztof; Havrdova, Eva; Stefoski, Dusan; Sprenger, Till; Montalban, Xavier; Cohan, Stanley; Umans, Kimberly; Greenberg, Steven; Ozen, Gulden; Elkins, Jacob
Journal:
BMC neurology
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination. (February 2021)

Authors:
Kappos, Ludwig; Cohan, Stanley; Arnold, Douglas L.; Robinson, Randy R.; Holman, Joan; Fam, Sami; Parks, Becky; Xiao, Shan; Castro-Borrero, Wanda
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study. (May 2018)

Authors:
Benedict, Ralph HB; Cohan, Stanley; Lynch, Sharon G; Riester, Katherine; Wang, Ping; Castro-Borrero, Wanda; Elkins, Jacob; Sabatella, Guido
Journal:
Multiple sclerosis
Issue:
Volume 24:Number 6(2018)
Page Start:
795
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center. (June 2018)

Authors:
Smoot, Kyle; Spinelli, Kateri J; Stuchiner, Tamela; Lucas, Lindsay; Chen, Chiayi; Grote, Lois; Baraban, Elizabeth; Kresa-Reahl, Kiren; Cohan, Stanley
Journal:
Multiple sclerosis
Issue:
Volume 24:Number 7(2018)
Page Start:
942
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Addressing the targeting range of the ABILHAND-56 in relapsing–remitting multiple sclerosis: A mixed methods psychometric study. Issue 2 (May 2018)

Authors:
Cleanthous, Sophie; Strzok, Sara; Pompilus, Farrah; Cano, Stefan; Marquis, Patrick; Cohan, Stanley; Goldman, Myla D; Kresa-Reahl, Kiren; Petrillo, Jennifer; Castrillo-Viguera, Carmen; Cadavid, Diego; Chen, Shih-Yin
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 4:Issue 2(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study. Issue 2 (June 2018)

Authors:
Strzok, Sara; Cleanthous, Sophie; Pompilus, Farrah; Cano, Stefan J; Marquis, Patrick; Cohan, Stanley; Goldman, Myla D; Kresa-Reahl, Kiren; Petrillo, Jennifer; Castrillo-Viguera, Carmen; Cadavid, Diego; Chen, Shih-Yin
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 4:Issue 2(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗